An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Clinical trial NCT00489385 · COMPLETED
Trial details
- NCT number
- NCT00489385
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-18
- Primary completion
- 2011-03-15
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.